Capital Research Global Investors

13F Holdings History for VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)

Symbol: VRTX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 14.5M shares
Security Ownership: 5.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Capital Research Global Investors ownership in VERTEX PHARMACEUTICALS INC / MA Common Stock (VRTX)

2025-05-13 - Capital Research Global Investors has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 14.5M shares of VERTEX PHARMACEUTICALS INC / MA Common Stock (VRTX). This represents 5.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Capital Research Global Investors	5.7%		$7.04B	14.5M			$484.22	13G	3/31/2025	13 May 2025 11:32:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	1.44%	+0.14%	$7.17B	16.1M	+1,571,947	+10.8%	$445.20	Q2 2025
3/31/2025	1.53%	+0.43%	$7.05B	14.5M	+4,107,393		$484.83	Q1 2025
12/31/2024	0.86%	+0.12%	$4.2B	10.4M	+1,426,746	+15.8%	$402.70	Q4 2024
9/30/2024	0.87%	+0.04%	$4.19B	9M	+462,866	+5.42%	$465.08	Q3 2024
6/30/2024	0.88%	+0.3%	$4B	8.54M	+2,795,457	+48.7%	$468.72	Q2 2024
3/31/2024	0.54%	+0.22%	$2.4B	5.74M	+2,176,218	+61%	$418.01	Q1 2024
12/31/2023	0.36%	+0.02%	$1.45B	3.57M	+195,080	+5.78%	$406.89	Q4 2023
9/30/2023	0.32%	+0.03%	$1.17B	3.37M	+310,908	+10.2%	$347.74	Q3 2023
6/30/2023	0.29%	+0.21%	$1.08B	3.06M	+2,251,781	+278%	$351.91	Q2 2023
3/31/2023	0.07%	+0.07%	$255M	810K	+809,895	NEW	$315.07	Q1 2023
12/31/2020		-0.1%	$0	0	-1,250,658	-100%		Q4 2020
9/30/2020	0.1%		$340M	1.25M	-1	0%	$272.12	Q3 2020
6/30/2020	0.11%		$363M	1.25M	-5	0%	$290.31	Q2 2020
3/31/2020	0.12%	+0%	$298M	1.25M	+15	+0%	$237.95	Q1 2020
12/31/2019	0.08%	+0%	$274M	1.25M	+379	+0.03%	$218.95	Q4 2019
9/30/2019	0.07%	+0%	$212M	1.25M	+22	+0%	$169.42	Q3 2019
6/30/2019	0.07%	+0%	$229M	1.25M	+248	+0.02%	$183.38	Q2 2019
3/31/2019	0.07%	-0.05%	$230M	1.25M	-815,018	-39.5%	$183.95	Q1 2019
12/31/2018	0.12%	-0.03%	$342M	2.07M	-590,000	-22.2%	$165.71	Q4 2018
9/30/2018	0.15%	+0.15%	$512M	2.66M	+2,655,018	NEW	$192.74	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.